Effect of time interval between surgery and preoperative chemoradiotherapy with 5-fluorouracil (5-FU) or 5-FU/oxaliplatin (5FU/OX) for rectal cancer

被引：1
|
作者：
Dolinsky, CM
Mahmoud, NN
Mick, R
Sun, W
Whittington, RW
Solin, LJ
Haller, DG
Fry, RD
Metz, JM
机构：
[1] Univ Penn, Sch Med, Dept Radiat Oncol, Philadelphia, PA 19104 USA
[2] Univ Penn, Sch Med, Dept Surg, Philadelphia, PA 19104 USA
[3] Univ Penn, Sch Med, Dept Biostat & Epidemiol, Philadelphia, PA 19104 USA
[4] Univ Penn, Sch Med, Div Hematol Oncol, Dept Med, Philadelphia, PA 19104 USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2005年 / 63卷 / 02期
关键词：
D O I：
10.1016/j.ijrobp.2005.07.472
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2078
引用
收藏
页码：S277 / S277
页数：1
相关论文
共 50 条
  • [31] Intraoperative 5-fluorouracil (5-FU) with postoperative 5-FU injections versus postoperative injections only in primary trabeculectomies
    Urken, SI
    Skuta, GL
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1996, 37 (03) : 117 - 117
  • [32] Effect of 5-fluorouracil (5-FU) infusion in myocardial perfusion scans
    Bishiniotis, T
    Mouratidou, D
    Pentheroudakis, G
    Andreadis, C
    Katseas, G
    Litos, A
    Hatseras, D
    [J]. EUROPEAN JOURNAL OF CANCER, 1997, 33 : 60 - 60
  • [33] Pharmacokinetic (PK) interaction between 5-fluorouracil (5-FU) and oxaliplatin (L-OHP).
    Papamichael, D
    Joel, SP
    Seymour, M
    Richards, F
    Bowerbank, M
    Slevin, ML
    [J]. BRITISH JOURNAL OF CANCER, 1998, 78 : 12 - 12
  • [34] Oxaliplatin (LOHP) and 5-fluorouracil (5-FU) synergism in advanced colorectal cancer patients (ACRC)
    Meyer, V
    Delva, R
    Gamelin, E
    Lamezec, B
    Maillart, P
    DanquechinDorval, E
    Lortholary, A
    BoisdronCelle, M
    Maigre, M
    Brienza, S
    Cvitkovic, E
    Larra, F
    [J]. EUROPEAN JOURNAL OF CANCER, 1997, 33 : 746 - 746
  • [35] Topical delivery of 5-fluorouracil (5-FU) by 1,3-bisalkylcarbonyl-5-FU prodrugs
    Beall, HD
    Sloan, KB
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2002, 231 (01) : 43 - 49
  • [36] CHEMORADIOTHERAPY WITH 5-FU VERSUS CAPECITABINE ON RECTAL CANCER DOWNSTAGING
    Aguas, L.
    Salgado, M.
    Davila, C.
    Costa, A. S.
    Almeida, D.
    Barbosa, M.
    Caeiro, C.
    Sarmento, C.
    Marques, M.
    Damasceno, M.
    [J]. ANNALS OF ONCOLOGY, 2010, 21 : 211 - 211
  • [37] EXCRETION OF 5-FLUOROURACIL (5-FU) INTO PANCREATIC-JUICE
    TAKADA, T
    YASUDA, H
    UCHIYAMA, K
    HASEGAWA, H
    [J]. GASTROENTEROLOGY, 1993, 104 (04) : A454 - A454
  • [38] ISOLATED LIVER PERFUSION WITH 5-FLUOROURACIL (5-FU) IN MAN
    AIGNER, K
    WALTHER, H
    TONN, JC
    KRAHL, M
    WENZL, A
    MERKER, G
    SCHWEMMLE, K
    [J]. CHIRURG, 1982, 53 (09): : 571 - 573
  • [39] TOLERANCE FOR 5-FLUOROURACIL (5-FU) IN RODENTS RECEIVING HYPERALIMENTATION
    SOUCHON, EA
    COPELAND, EM
    WATSON, P
    DUDRICK, SJ
    [J]. FEDERATION PROCEEDINGS, 1974, 33 (03) : 692 - 692
  • [40] 5-FLUOROURACIL(5-FU) IN PRIMARY TRABECULECTOMY - A RANDOMIZED TRIAL
    LOFTFIELD, K
    BALL, SF
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1991, 32 (04) : 745 - 745
12345